Amgen (AMGN) Change in Cash (2009 - 2026)
Amgen's quarterly Change in Cash came in at $2.9 billion in Q1 2026, up 191.97% year-on-year from $996.3 million in Q1 2025, and up 1020.57% quarter-over-quarter from -$316.0 million in Q4 2025.
Amgen has reported Change in Cash for 18 years, with the latest figure at $2.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 191.97% year-over-year to $2.9 billion; the trailing twelve-month figure through Mar 2026 stood at $3.2 billion (up 459.47% YoY), and the FY2025 full-year result was -$2.8 billion, down 376.38% from the prior year.
- Change in Cash for Q1 2026 stood at $2.9 billion, up from -$316.0 million in the prior quarter.
- The five-year high for Change in Cash was $23.9 billion in Q1 2023, with the low at -$23.8 billion in Q4 2023.
- Average Change in Cash over 5 years is $238.2 million, with a median of -$316.0 million recorded in 2025.
- Peak annual rise in Change in Cash reached 1737.99% in 2023, while the deepest fall reached 1170.53% in 2023.
- Tracing AMGN's Change in Cash over 5 years: stood at -$1.9 billion in 2022, then slumped by 1170.53% to -$23.8 billion in 2023, then soared by 112.45% to $3.0 billion in 2024, then slumped by 110.67% to -$316.0 million in 2025, then soared by 1020.57% to $2.9 billion in 2026.
- The last three Change in Cash figures came in at $2.9 billion (Q1 2026), -$316.0 million (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -1.99 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 1.98 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 4.16 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -9.29 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.91 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 65.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 563.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -635.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.91 Bn |
| Dec 31, 2025 | -316.00 Mn |
| Sep 30, 2025 | 1.42 Bn |
| Jun 30, 2025 | -782.00 Mn |
| Mar 31, 2025 | -3.16 Bn |
| Dec 31, 2024 | 2.96 Bn |
| Sep 30, 2024 | -290.00 Mn |
| Jun 30, 2024 | -407.00 Mn |
| Mar 31, 2024 | -1.24 Bn |
| Dec 31, 2023 | -23.80 Bn |
| Sep 30, 2023 | 493.00 Mn |
| Jun 30, 2023 | 2.69 Bn |
| Mar 31, 2023 | 23.93 Bn |
| Dec 31, 2022 | -1.87 Bn |
| Sep 30, 2022 | 4.30 Bn |
| Jun 30, 2022 | -1.33 Bn |
| Mar 31, 2022 | -1.46 Bn |
| Dec 31, 2021 | -3.98 Bn |
| Sep 30, 2021 | 5.34 Bn |
| Jun 30, 2021 | 518.00 Mn |
| Mar 31, 2021 | -154.00 Mn |
| Dec 31, 2020 | -2.82 Bn |
| Sep 30, 2020 | -58.00 Mn |
| Jun 30, 2020 | 1.46 Bn |
| Mar 31, 2020 | 1.65 Bn |
| Dec 31, 2019 | -5.38 Bn |
| Sep 30, 2019 | 5.89 Bn |
| Jun 30, 2019 | -1.83 Bn |
| Mar 31, 2019 | 413.00 Mn |
| Dec 31, 2018 | -5.01 Bn |
| Sep 30, 2018 | 1.83 Bn |
| Jun 30, 2018 | 390.00 Mn |
| Mar 31, 2018 | 5.94 Bn |
| Dec 31, 2017 | 800.00 Mn |
| Sep 30, 2017 | 371.00 Mn |
| Jun 30, 2017 | -729.00 Mn |
| Mar 31, 2017 | 117.00 Mn |
| Dec 31, 2016 | -244.00 Mn |
| Sep 30, 2016 | 855.00 Mn |
| Jun 30, 2016 | -266.00 Mn |
| Mar 31, 2016 | -1.25 Bn |
| Dec 31, 2015 | 918.00 Mn |
| Sep 30, 2015 | -569.00 Mn |
| Jun 30, 2015 | 931.00 Mn |
| Mar 31, 2015 | -867.00 Mn |
| Dec 31, 2014 | 54.00 Mn |
| Sep 30, 2014 | -675.00 Mn |
| Jun 30, 2014 | 665.00 Mn |
| Mar 31, 2014 | -118.00 Mn |
| Dec 31, 2013 | -4.48 Bn |
| Sep 30, 2013 | 2.48 Bn |
| Jun 30, 2013 | 3.28 Bn |
| Mar 31, 2013 | -727.00 Mn |
| Dec 31, 2012 | -2.57 Bn |
| Sep 30, 2012 | -26.00 Mn |
| Jun 30, 2012 | 1.64 Bn |
| Mar 31, 2012 | -2.74 Bn |
| Dec 31, 2011 | 3.06 Bn |
| Sep 30, 2011 | -2.11 Bn |
| Jun 30, 2011 | 4.73 Bn |
| Mar 31, 2011 | -2.02 Bn |
| Dec 31, 2010 | 336.00 Mn |
| Sep 30, 2010 | 1.24 Bn |
| Jun 30, 2010 | -554.00 Mn |
| Mar 31, 2010 | -618.00 Mn |
| Dec 31, 2009 | -693.00 Mn |
| Sep 30, 2009 | 609.00 Mn |
| Jun 30, 2009 | 191.00 Mn |
| Mar 31, 2009 | 1.00 Bn |